We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WIFI
1726
DELISTED
Boingo Wireless, Inc.
WIFI
$268K ﹤0.01%
20,091
– –
ANIK icon
1727
Anika Therapeutics
ANIK
$290M
$267K ﹤0.01%
7,087
– –
FLWS icon
1728
1-800-Flowers.com
FLWS
$262M
$267K ﹤0.01%
13,330
– –
BDTX icon
1729
Black Diamond Therapeutics
BDTX
$119M
$266K ﹤0.01%
6,317
– –
SRDX
1730
DELISTED
Surmodics
SRDX
$266K ﹤0.01%
6,159
– –
HSTM icon
1731
HealthStream
HSTM
$831M
$266K ﹤0.01%
12,016
– –
IMKTA icon
1732
Ingles Markets
IMKTA
$1.7B
$266K ﹤0.01%
6,173
– –
EIDX
1733
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$266K ﹤0.01%
5,576
– –
PLCE icon
1734
Children's Place
PLCE
$55.6M
$266K ﹤0.01%
7,101
– –
HA
1735
DELISTED
Hawaiian Holdings, Inc.
HA
$265K ﹤0.01%
18,895
– –
APOG icon
1736
Apogee Enterprises
APOG
$899M
$264K ﹤0.01%
11,475
– –
AMRX icon
1737
Amneal Pharmaceuticals
AMRX
$6.15B
$263K ﹤0.01%
55,273
– –
PAHC icon
1738
Phibro Animal Health
PAHC
$1.38B
$263K ﹤0.01%
9,993
– –
BCEL
1739
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$262K ﹤0.01%
12,320
+3,904
+46% +$69K
AMK
1740
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$262K ﹤0.01%
9,605
+3,129
+48% +$76.6K
CRBP icon
1741
Corbus Pharmaceuticals
CRBP
$191M
$261K ﹤0.01%
1,038
– –
SPNT icon
1742
SiriusPoint
SPNT
$2.68B
$261K ﹤0.01%
34,789
– –
BRSP
1743
BrightSpire Capital
BRSP
$633M
$261K ﹤0.01%
37,213
– –
BTAI icon
1744
BioXcel Therapeutics
BTAI
$34M
$261K ﹤0.01%
+308
New +$201K
URGN icon
1745
UroGen Pharma
URGN
$2.4B
$261K ﹤0.01%
9,990
– –
QCRH icon
1746
QCR Holdings
QCRH
$1.74B
$260K ﹤0.01%
8,339
+2,529
+44% +$72.9K
ECOM
1747
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$260K ﹤0.01%
16,397
+5,994
+58% +$69.3K
BMTC
1748
DELISTED
Bryn Mawr Bank Corp
BMTC
$260K ﹤0.01%
9,382
– –
MDP
1749
DELISTED
Meredith Corporation
MDP
$259K ﹤0.01%
17,831
-23,074
-56% -$336K
IMAX icon
1750
IMAX
IMAX
$2.85B
$258K ﹤0.01%
23,016
– –
68 69
70
71 72

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.